Please login or register first to view this content.
Cardiovascular Disease Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
COVID-19 Vaccine Does Not Increase CV Event Risk in Those With Existing Disease
USPSTF Recommends Against Vitamin E, Beta-Carotene Use for CVD and Cancer Prevention
Eplontersen Bests Placebo in Hereditary Transthyretin-Mediated Amyloid Polyneuropathy Study
New Data Prompt FDA Review Period Extension for Omecamtiv Mecarbil
IV Vitamin C Increases Risk for Death, Organ Failure in Sepsis
COVID-19 Vaccines Cut Mortality With Heart Failure
Amvuttra Approved for Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis
ADA: Tirzepatide Improves Kidney Outcomes in T2DM With Increased CV Risk
Heart Failure Hospitalization Risk Compared With Empagliflozin vs Other Glucose-Lowering Txs
Updates Issued for Standards of Medical Care in Diabetes
NDA Submitted for Landiolol, a Highly Cardioselective Beta Blocker
Unsweetened, Sugar-Sweetened Coffee Intake Linked to Mortality
No Increase in Long-Term Mortality Seen With Peripheral Drug-Coated Devices
Metformin, Lifestyle Changes Cut Risk for T2DM, But Not CVD
Aspirin May Lower Cardiovascular Risks in Chronic Kidney Disease Population
Gout Drug May Cut Mortality in Heart Failure Hospitalizations
Dry Powder Inhaler Containing Treprostinil Gets FDA Approval
Risk for Hospitalization for Heart Failure Down With SGLT-2i Treatment for T2D
